Barclays
CGNT

Barclays’s Cogentix Medical, Inc. CGNT Stock Holding History

Barclays’s Portfolio CGNT Stock Details CGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-12,600
Closed -$49K – 7607
2018
Q1 		$49K Buy
12,600
+2,200
+21% +$6.88K ﹤0.01% 5922
2017
Q4 		$33K Buy
+10,400
New +$30K ﹤0.01% 6008

Barclays's CGNT Position: Q2 2018 in Review

Barclays sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 12,600 shares — an estimated $49K sold.

Barclays first reported a position in CGNT in Q4 2017 and held it in 2 quarters. The position peaked at $49K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

  • Barclays reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
  • Barclays sold 12,600 Cogentix Medical, Inc. shares in Q2 2018, an estimated $49K.
  • Barclays first reported a position in Cogentix Medical, Inc. in Q4 2017 and held it in 2 quarters.
  • Barclays's Cogentix Medical, Inc. position peaked at $49K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.